FDA Approves METHOTREXATE — Alembic Pharmaceuticals Inc.

# FDA Approves Alembic Pharmaceuticals' Generic Methotrexate Sodium Injection Alembic Pharmaceuticals Inc. has received FDA approval for its generic methotrexate sodium injection for intramuscular administration, expanding treatment options in the competitive market for this widely-used immunosuppressant and antimetabolite therapy. The approval is expected to increase price competition and improve patient access to methotrexate across oncology, rheumatology, and autoimmune disease indications.